Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmyocardial laser revascularization: current experience and future direction

R J March1

  • 1Department of Cardiovascular-Thoracic Surgery, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.

Journal of Clinical Laser Medicine & Surgery
|June 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transmyocardial CO(2) laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial.

The American journal of medicine·2001
Same author

Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser.

Circulation·2001
Same author

Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

The New England journal of medicine·1999
Same author

Placement of a PTFE-covered Wallstent through a 12 Fr sheath for the exclusion of a common iliac artery aneurysm.

Cardiovascular and interventional radiology·1999
Same author

Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.

Infection and immunity·1999
Same author

Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial.

Seminars in thoracic and cardiovascular surgery·1999

Transmyocardial laser revascularization (TMR) improves quality of life and survival for end-stage coronary artery disease patients. Careful patient selection and perioperative management are key for successful TMR outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Procedures
  • Laser Therapy in Medicine

Background:

  • End-stage coronary artery disease (CAD) significantly impacts patient quality of life and survival.
  • Transmyocardial laser revascularization (TMR) is an emerging therapy for patients with refractory angina.
  • Previous studies suggest potential benefits of TMR in improving cardiac function.

Purpose of the Study:

  • To evaluate the clinical outcomes of Transmyocardial laser revascularization (TMR) in end-stage coronary artery disease patients.
  • To identify critical factors for successful TMR, including patient selection and perioperative management.
  • To report on the experience gained at Rush-Presbyterian-St. Luke's Medical Center as a clinical investigation site.

Main Methods:

Related Experiment Videos

  • Retrospective analysis of seventy-nine patients undergoing TMR under FDA protocols.
  • Sixty-three patients received sole TMR via a minimally invasive approach on a beating heart.
  • Detailed review of anesthetic support, patient selection criteria, and perioperative management strategies.

    • Main Results:

    • Transmyocardial laser revascularization (TMR) demonstrated positive effects on quality of life and event-free survival.
    • Minimally invasive TMR on a beating heart was feasible in the majority of patients.
    • Key lessons were learned regarding optimization of patient selection and perioperative care.

    Conclusions:

    • Transmyocardial laser revascularization (TMR) is a viable option for select end-stage coronary artery disease patients.
    • Optimized patient selection and meticulous perioperative management are crucial for TMR success.
    • Further investigation into TMR's long-term efficacy and broader applications is warranted.